QURE SCHEDULE 13G/A: SEC filing
A Schedule 13G/A amendment was
Filed with the SEC on · accession 0000019617-26-000387
QURE filed a SCHEDULE 13G/A (schedule 13g/a) with the SEC on Oct 16, 2026. A Schedule 13G/A amendment was filed regarding beneficial ownership of uniQure N.V. (QURE) common shares. The stock moved -3.3% by the first close after the filing.
Summary of the filing
A Schedule 13G/A amendment was filed regarding beneficial ownership of uniQure N.V. (QURE) common shares. The filing indicates a change in a previously reported passive ownership position.
Key details
How QURE stock reacted
Close before
$22.52
Oct 15, 2026
First close after
-3.29%
$21.78
5 trading days
+2.62%
$23.11
Since filing
-6.71%
$21.01
✦ Ask GOAX AI about this filing — what it means for QURE, what changed since its last filings and what to watch next.
Try it free for 7 days🔔 Want to stay updated on new SEC filings for QURE?
Click hereFrequently asked questions
What did QURE file with the SEC on Oct 16, 2026?
QURE filed a SCHEDULE 13G/A (SEC filing). A Schedule 13G/A amendment was filed regarding beneficial ownership of uniQure N.V. (QURE) common shares. The filing indicates a change in a previously reported passive ownership position.
How do I read a SCHEDULE 13G/A?
A report the company filed with the SEC (the US market regulator). Start with the summary, then the key amounts and names. Compare it with the company’s earlier filings.
Why are SEC filings important?
Public companies must tell the SEC about anything that can change their value — results, leadership changes, big deals, new shares, bankruptcy. Filings are the official source, often before the news. A SCHEDULE 13G/A (schedule 13g/a): A report the company filed with the SEC (the US market regulator).
How did QURE stock react to this filing?
QURE closed at $22.52 before the filing and $21.78 on Oct 16, 2026 (-3.29%). Five trading days later: $23.11 (+2.62%).
Other QURE SEC filings
- 8-K · SEC filingNov 4, 2026
- 10-Q · SEC filingNov 4, 2026
- 8-K · SEC filingNov 2, 2026
- 8-K · SEC filingSep 29, 2026
- 8-K · Fda approvalSep 2, 2026
- 8-K · SEC filingJul 29, 2026
- 10-Q · SEC filingJul 29, 2026
- 144 · Insider sale plannedJul 2, 2026
- 144 · Insider sale plannedJun 30, 2026
- 144 · Insider sale plannedJun 30, 2026
Get alerts when QURE files with the SEC, plus live charts, key levels and news for 13,000+ stocks.
Try SEPT free for 7 days